PLAGL2 and central nervous system cancer: Amplification and subsequent overexpression of PLAGL2 was also shown to suppress differentiation in neural stem cells and glioma-initiating cells, in part through aberrant Wnt/β-Catenin signaling in malignant glioma [71].